Skip to main content

NEUBERGER BERMAN GROUP LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1465109 NEW YORK, NY

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,965,010
+$19,193,309 QoQ
Shares Held
267,855
+877.1% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $1,467,551,041 across 98 Biotechnology names. HALO ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,965,010 267,855
2026-03-31 $1,771,701 27,413
2025-12-31 $1,812,792 26,936
2025-09-30 $2,036,944 27,774
2025-06-30 $9,498,851 182,600
2025-03-31 $29,513,847 462,527
2024-12-31 $17,954,853 375,546
2024-09-30 $16,375,333 286,082
2024-06-30 $14,504,923 277,023
2024-03-31 $10,563,823 259,681
2023-12-31 $6,521,812 176,456
2023-09-30 $7,046,104 184,453
2023-06-30 $6,597,599 182,911
2023-03-31 $5,397,048 141,321
2022-12-31 $7,648,042 134,412
2022-09-30 $7,048,439 178,261
2022-06-30 $7,715,576 175,354
2022-03-31 $6,631,046 166,275
2021-12-31 $6,410,317 159,421
2021-09-30 $6,503,064 159,859
2021-06-30 $10,492,524 231,062
2021-03-31 $8,886,431 213,155
2020-12-31 $6,353,368 148,756
2020-09-30 $3,856,590 146,750
2020-06-30 $3,022,827 112,750
2020-03-31 $1,434,702 79,750